As readers will have noticed, my wife and I have spent a lot of time talking to medical practitioners in recent months. The same readers will also know that my wife is a Structural Biologist, whose work I have featured before in Data Visualisation – A Scientific Treatment. Some of our previous medical interactions had led to me thinking about the nexus between medical science and statistics . More recently, my wife had a discussion with a doctor which brought to mind some of her own previous scientific work. Her observations about the connections between these two areas have formed the genesis of this article. While the origins of this piece are in science and medicine, I think that the learnings have broader applicability.
So the general context is a medical test, the result of which was my wife being told that all was well . Given that humans are complicated systems (to say the very least), my wife was less than convinced that just because reading X was OK it meant that everything else was also necessarily OK. She contrasted the approach of the physician with something from her own experience and in particular one of the experiments that formed part of her PhD thesis. I’m going to try to share the central point she was making with you without going in to all of the scientific details . However to do this I need to provide at least some high-level background.
Structural Biology is broadly the study of the structure of large biological molecules, which mostly means proteins and protein assemblies. What is important is not the chemical make up of these molecules (how many carbon, hydrogen, oxygen, nitrogen and other atoms they consist of), but how these atoms are arranged to create three dimensional structures. An example of this appears below:
This image is of a bacterial Ribosome. Ribosomes are miniature machines which assemble amino acids into proteins as part of the chain which converts information held in DNA into useful molecules . Ribosomes are themselves made up of a number of different proteins as well as RNA.
In order to determine the structure of a given protein, it is necessary to first isolate it in sufficient quantity (i.e. to purify it) and then subject it to some form of analysis, for example X-ray crystallography, electron microscopy or a variety of other biophysical techniques. Depending on the analytical procedure adopted, further work may be required, such as growing crystals of the protein. Something that is generally very important in this process is to increase the stability of the protein that is being investigated . The type of protein that my wife was studying  is particularly unstable as its natural home is as part of the wall of cells – removed from this supporting structure these types of proteins quickly degrade.
So one of my wife’s tasks was to better stabilise her target protein. This can be done in a number of ways  and I won’t get into the technicalities. After one such attempt, my wife looked to see whether her work had been successful. In her case the relative stability of her protein before and after modification is determined by a test called a Thermostability Assay.
In the image above, you can see the combined results of several such assays carried out on both the unmodified and modified protein. Results for the unmodified protein are shown as a green line  and those for the modified protein as a blue line . The fact that the blue line (and more particularly the section which rapidly slopes down from the higher values to the lower ones) is to the right of the green one indicates that the modification has been successful in increasing thermostability.
So my wife had done a great job – right? Well things were not so simple as they might first seem. There are two different protocols relating to how to carry out this thermostability assay. These basically involve doing some of the required steps in a different order. So if the steps are A, B, C and D, then protocol #1 consists of A ↦ B ↦ C ↦ D and protocol #2 consists of A ↦ C ↦ B ↦ D. My wife was thorough enough to also use this second protocol with the results shown below:
Here we have the opposite finding, the same modification to the protein seems to have now decreased its stability. There are some good reasons why this type of discrepancy might have occurred , but overall my wife could not conclude that this attempt to increase stability had been successful. This sort of thing happens all the time and she moved on to the next idea. This is all part of the rather messy process of conducting science .
I’ll let my wife explain her perspective on these results in her own words:
In general you can’t explain everything about a complex biological system with one set of data or the results of one test. It will seldom be the whole picture. Protocol #1 for the thermostability assay was the gold standard in my lab before the results I obtained above. Now protocol #1 is used in combination with another type of assay whose efficacy I also explored. Together these give us an even better picture of stability. The gold standard shifted. However, not even this bipartite test tells you everything. In any complex system (be that Biological or a complicated dataset) there are always going to be unknowns. What I think is important is knowing what you can and can’t account for. In my experience in science, there is generally much much more that can’t be explained than can.
As ever translating all of this to a business context is instructive. Conscientious Data Scientists or business-focussed Statisticians who come across something interesting in a model or analysis will always try (where feasible) to corroborate this by other means; they will try to perform a second “experiment” to verify their initial findings. They will also realise that even two supporting results obtained in different ways will not in general be 100% conclusive. However the highest levels of conscientiousness may be more honoured in breach than observance . Also there may not be an alternative “experiment” that can be easily run. Whatever the motivations or circumstances, it is not beyond the realm of possibility that some Data Science findings are true only in the same way that my wife thought she had successfully stabilised her protein before carrying out the second assay.
I would argue that business will often have much to learn from the levels of rigour customary in most scientific research . It would be nice to think that the same rigour is always applied in commercial matters as academic ones. Unfortunately experience would tend to suggest the contrary is sometimes the case. However, it would also be beneficial if people working on statistical models in industry went out of their way to stress not only what phenomena these models can explain, but what they are unable to explain. Knowing what you don’t know is the first step towards further enlightenment.
Indeed this previous article had a sub-section titled Rigour and Scrutiny, echoing some of the themes in this piece.
Chopping off flexible sections, adding other small proteins which act as scaffolding, getting antibodies or other biological molecules to bind to the protein and so on.
Actually a sigmoidal dose-response curve.
For anyone with colour perception problems, the green line has markers which are diamonds and the blue line has markers which are triangles.
As my wife writes [with my annotations]:
A possible explanation for this effect was that while T4L [the protein she added to try to increase stability – T4 Lysozyme] stabilised the binding pocket, the other domains of the receptor were destabilised. Another possibility was that the introduction of T4L caused an increase in the flexibility of CL3, thus destabilising the receptor. A method for determining whether this was happening would be to introduce rigid linkers at the AT1R-T4L junction [AT1R was the protein she was studying, angiotensin II type 1 receptor], or other placements of T4L. Finally AT1R might exist as a dimer and the addition of T4L might inhibit the formation of dimers, which could also destabilise the receptor.
This blog touches on a wide range of topics, including social media, cultural transformation, general technology and – last but not least – sporting analogies. However, its primary focus has always been on data and information-centric matters in a business context. Having said this, all but the more cursory of readers will have noted the prevalence of pieces with a Mathematical or Scientific bent. To some extent this is a simple reflection of the author’s interests and experience, but a stronger motivation is often to apply learnings from different fields to the business data arena. This article is probably more scientific in subject matter than most, but I will also look to highlight some points pertinent to commerce towards the end.
The topic I want to turn my attention to in this article is public trust in science. This is a subject that has consumed many column inches in recent years. One particular area of focus has been climate science, which, for fairly obvious political reasons, has come in for even more attention than other scientific disciplines of late. It would be distracting to get into the arguments about climate change and humanity’s role in it here  and in a sense this is just the latest in a long line of controversies that have somehow become attached to science. An obvious second example here is the misinformation circling around both the efficacy and side effects of vaccinations . In both of these cases, it seems that at least a sizeable minority of people are willing to query well-supported scientific findings. In some ways, this is perhaps linked to the general mistrust of “experts” and “elites”  that was explicitly to the fore in the UK’s European Union Referendum debate .
“People in this country have had enough of experts”
– Michael Gove , at this point UK Justice Secretary and one of the main proponents of the Leave campaign, speaking on Sky News, June 2016.
Mr Gove was talking about economists who held a different point of view to his own. However, his statement has wider resonance and cannot be simply dismissed as the misleading sound-bite of an experienced politician seeking to press his own case. It does indeed appear that in many places around the world experts are trusted much less than they used to be and that includes scientists.
“Many political upheavals of recent years, such as the rise of populist parties in Europe, Donald Trump’s nomination for the American presidency and Britain’s vote to leave the EU, have been attributed to a revolt against existing elites.”
A Brief  History of the Public Perception of Science
Note: This section is focussed on historical developments in the public’s trust in science. If the reader would like to skip on to more toast-centric content, then please click here.
Answering questions about the erosion of trust in politicians and the media is beyond the scope of this humble blog. Wondering what has happened to trust in science is firmly in its crosshairs. One part of the answer is that – for some time – scientists were held in too much esteem and the pendulum was inevitably going to swing back the other way. For a while the pace of scientific progress and the miracles of technology which this unleashed placed science on a pedestal from which there was only one direction of travel. During this period in which science was – in general – uncritically held in great regard, the messy reality of actual science was never really highlighted. The very phrase “scientific facts” is actually something of an oxymoron. What we have is instead scientific theories. Useful theories are consistent with existing observations and predict new phenomena. However – as I explained in Patterns patterns everywhere – a theory is only as good as the latest set of evidence and some cherished scientific theories have been shown to be inaccurate; either in general, or in some specific circumstances . However saying “we have a good model that helps us explain many aspects of a phenomenon and predict more, but it doesn’t cover everything and there are some uncertainties” is a little more of a mouthful than “we have discovered that…”.
There have been some obvious landmarks along the way to science’s current predicament. The unprecedented destruction unleashed by the team working on the Manhattan Project at first made the scientists involved appear God-like. It also seemed to suggest that the path to Great Power status was through growing or acquiring the best Physicists. However, as the prolonged misery caused in Japan by the twin nuclear strikes became more apparent and as the Cold War led to generations living under the threat of mutually assured destruction, the standing attached by the general public to Physicists began to wane; the God-like mantle began to slip. While much of our modern world and its technology was created off the back of now fairly old theories like Quantum Chromodynamics and – most famously – Special and General Relativity, the actual science involved became less and less accessible to the man or woman in the street. For all the (entirely justified) furore about the detection of the Higgs Boson, few people would be able to explain much about what it is and how it fits into the Standard Model of particle physics.
In the area of medicine and pharmacology, the Thalidomide tragedy, where a drug prescribed to help pregnant women suffering from morning sickness instead led to terrible birth defects in more than 10,000 babies, may have led to more stringent clinical trials, but also punctured the air of certainty that had surrounded the development of the latest miracle drug. While medical science and related disciplines have vastly improved the health of much of the globe, the glacial progress in areas such as oncology has served as a reminder of the fallibility of some scientific endeavours. In a small way, the technical achievements of that apogee of engineering, NASA, were undermined by loss of crafts and astronauts. Most notably the Challenger and Columbia fatalities served to further remove the glossy veneer that science had acquired in the 1940s to 1960s.
Lest it be thought at this point that I am decrying science, or even being anti-scientific, nothing could be further from the truth. I firmly believe that the ever growing body of scientific knowledge is one of humankind’s greatest achievements, if not its greatest. From our unpromising vantage point on an unremarkable little planet in our equally common-all-garden galaxy we have been able to grasp many of the essential truths about the whole Universe from the incomprehensibly gigantic to the most infinitesimal constituent of a sub-atomic particle. However, it seems that many people do not fully embrace the grandeur of our achievements, or indeed in many cases the unexpected beauty and harmony that they have revealed . It is to the task of understanding this viewpoint that I am addressing my thoughts.
More recently, the austerity that has enveloped much of the developed world since the 2008 Financial Crisis has had two reinforcing impacts on science in many countries. First funding has often been cut, leading to pressure on research programmes and scientists increasingly having to make an economic case for their activities; a far cry from the 1950s. Second, income has been effectively stagnant for the vast majority of people, this means that scientific expenditure can seem something of a luxury and also fuels the anti-elite feelings cited by The Economist earlier in this article.
Into this seeming morass steps Anita Makri, “editor/writer/producer and former research scientist”. In a recent Nature article she argues that the form of science communicated in popular media leaves the public vulnerable to false certainty. I reproduce some of her comments here:
“Much of the science that the public knows about and admires imparts a sense of wonder and fun about the world, or answers big existential questions. It’s in the popularization of physics through the television programmes of physicist Brian Cox and in articles about new fossils and quirky animal behaviour on the websites of newspapers. It is sellable and familiar science: rooted in hypothesis testing, experiments and discovery.
Although this science has its place, it leaves the public […] with a different, outdated view to that of scientists of what constitutes science. People expect science to offer authoritative conclusions that correspond to the deterministic model. When there’s incomplete information, imperfect knowledge or changing advice — all part and parcel of science — its authority seems to be undermined. […] A popular conclusion of that shifting scientific ground is that experts don’t know what they’re talking about.”
After my speculations about the reasons why science is held in less esteem than once was the case, I’ll return to more prosaic matters; namely food and specifically that humble staple of many a breakfast table, toast. Food science has often fared no better than its brother disciplines. The scientific guidance issued to people wanting to eat healthily can sometimes seem to gyrate wildly. For many years fat was the source of all evil, more recently sugar has become public enemy number one. Red wine was meant to have beneficial effects on heart health, then it was meant to be injurious; I’m not quite sure what the current advice consists of. As Makri states above, when advice changes as dramatically as it can do in food science, people must begin to wonder whether the scientists really know anything at all.
So where does toast fit in? Well the governmental body charged with providing advice about food in the UK is called the Food Standards Agency. They describe their job as “using our expertise and influence so that people can trust that the food they buy and eat is safe and honest.” While the FSA do sterling work in areas such as publicly providing ratings of food hygiene for restaurants and the like, their most recent campaign is one which seems at best ill-advised and at worst another nail in the public perception of the reliability of scientific advice. Such things matter because they contribute to the way that people view science in general. If scientific advice about food is seen as unsound, surely there must be questions around scientific advice about climate change, or vaccinations.
Before I am accused of belittling the FSA’s efforts, let’s consider the campaign in question, which is called Go for Gold and encourages people to consume less acrylamide. Here is some of what the FSA has to say about the matter:
“Today, the Food Standards Agency (FSA) is launching a campaign to ‘Go for Gold’, helping people understand how to minimise exposure to a possible carcinogen called acrylamide when cooking at home.
Acrylamide is a chemical that is created when many foods, particularly starchy foods like potatoes and bread, are cooked for long periods at high temperatures, such as when baking, frying, grilling, toasting and roasting. The scientific consensus is that acrylamide has the potential to cause cancer in humans.
as a general rule of thumb, aim for a golden yellow colour or lighter when frying, baking, toasting or roasting starchy foods like potatoes, root vegetables and bread.”
The BBC has been obsessed with neutrality on all subjects recently , but in this case they did insert the reasonable counterpoint that:
“However, Cancer Research UK  said the link was not proven in humans.”
Acrylamide is certainly a nasty chemical. Amongst other things, it is used in polyacrylamide gel electrophoresis, a technique used in biochemistry. If biochemists mix and pour their own gels, they have to monitor their exposure and there are time-based and lifetime limits as to how often they can do such procedures . Acrylamide has also been shown to lead to cancer in mice. So what could be more reasonable that the FSA’s advice?
Food Safety – A Statistical / Risk Based Approach
Earlier I introduced Anita Makri, it is time to meet our second protagonist, David Spiegelhalter, Winton Professor for the Public Understanding of Risk in the Statistical Laboratory, Centre for Mathematical Sciences, University of Cambridge . Professor Spiegelhalter has penned a response to the FSA’s Go for Gold campaign. I feel that this merits reading in entirety, but here are some highlights:
“Very high doses [of Acrylamide] have been shown to increase the risk of mice getting cancer. The IARC (International Agency for Research on Cancer) considers it a ‘probable human carcinogen’, putting it in the same category as many chemicals, red meat, being a hairdresser and shift-work.
However, there is no good evidence of harm from humans consuming acrylamide in their diet: Cancer Research UK say that ‘At the moment, there is no strong evidence linking acrylamide and cancer.’
This is not for want of trying. A massive report from the European Food Standards Agency (EFSA) lists 16 studies and 36 publications, but concludes
‘In the epidemiological studies available to date, AA intake was not associated with an increased risk of most common cancers, including those of the GI or respiratory tract, breast, prostate and bladder. A few studies suggested an increased risk for renal cell, and endometrial (in particular in never-smokers) and ovarian cancer, but the evidence is limited and inconsistent. Moreover, one study suggested a lower survival in non-smoking women with breast cancer with a high pre-diagnostic exposure to AA but more studies are necessary to confirm this result. (p185)’
[Based on the EFSA study] adults with the highest consumption of acrylamide could consume 160 times as much and still only be at a level that toxicologists think unlikely to cause increased tumours in mice.
This all seems rather reassuring, and may explain why it’s been so difficult to observe any effect of acrylamide in diet.”
Indeed, Professor Spiegelhalter, an esteemed statistician, also points out that most studies will adopt the standard criteria for statistical significance. Given that such significance levels are often set at 5%, then this means that:
“[As] each study is testing an association with a long list of cancers […], we would expect 1 in 20 of these associations to be positive by chance alone.”
He closes his article by stating – not unreasonably – that the FSA’s time and attention might be better spent on areas where causality between an agent and morbidity is well-established, for example obesity. My assumption is that the FSA has a limited budget and has to pick and choose what food issues to weigh in on. Even if we accept for the moment that there is some slight chance of a causal link between the consumption of low levels of acrylamide and cancer, there are plenty of other areas in which causality is firmly established; obesity as mentioned by Professor Spiegelhalter, excessive use of alcohol, even basic kitchen hygiene. It is hard to understand why the FSA did not put more effort into these and instead focussed on an area where the balance of scientific judgement is that there is unlikely to be an issue.
Having a mathematical background perhaps biases me, but I tend to side with Professor Spiegelhalter’s point of view. I don’t want to lay the entire blame for the poor view that some people have of science at the FSA’s door, but I don’t think campaigns like Go for Gold help very much either. The apocryphal rational man or woman will probably deduce that there is not an epidemic of acrylamide poisoning in progress. This means that they may question what the experts at the FSA are going on about. In turn this reduces respect for other – perhaps more urgent – warnings about food and drink. Such a reaction is also likely to colour how the same rational person thinks about “expert” advice in general. All of this can contribute to further cracks appearing in the public edifice of science, an outcome I find very unfortunate.
So what is to be done?
A Call for a New and More Honest Approach to Science Communications
As promised I’ll return to Anita Makri’s thoughts in the same article referenced above:
“It’s more difficult to talk about science that’s inconclusive, ambivalent, incremental and even political — it requires a shift in thinking and it does carry risks. If not communicated carefully, the idea that scientists sometimes ‘don’t know’ can open the door to those who want to contest evidence.
Scientists can influence what’s being presented by articulating how this kind of science works when they talk to journalists, or when they advise on policy and communication projects. It’s difficult to do, because it challenges the position of science as a singular guide to decision making, and because it involves owning up to not having all of the answers all the time while still maintaining a sense of authority. But done carefully, transparency will help more than harm. It will aid the restoration of trust, and clarify the role of science as a guide.”
The scientific method is meant to be about honesty. You record what you see, not what you want to see. If the data don’t support your hypothesis, you discard or amend your hypothesis. The peer-review process is meant to hold scientists to the highest levels of integrity. What Makri seems to be suggesting is for scientists to turn their lenses on themselves and how they communicate their work. Being honest where there is doubt may be scary, but not as scary as being caught out pushing certainty where no certainty is currently to be had.
At the beginning of this article, I promised that I would bring things back to a business context. With lots of people with PhDs in numerate sciences now plying their trade as data scientists and the like, there is an attempt to make commerce more scientific . Understandably, the average member of a company will have less of an appreciation of statistics and statistical methods than their data scientists do. This can lead to data science seeming like magic; the philosopher’s stone . There are obvious parallels here with how Physicists were seen in the period immediately after the Second World War.
Earlier in the text, I mused about what factors may have led to a deterioration in how the public views science and scientists. I think that there is much to be learnt from the issues I have covered in this article. If data scientists begin to try to peddle absolute truth and perfect insight (both of which, it is fair to add, are often expected from them by non-experts), as opposed to ranges of outcomes and probabilities, then the same decline in reputation probably awaits them. Instead it would be better if data scientists heeded Anita Makri’s words and tried to always be honest about what they don’t know as well as what they do.
Save to note that there really is no argument in scientific circles.
For a primer on the area, you could do worse than watching The Royal Society‘s video:
For the record, my daughter has had every vaccine known to the UK and US health systems and I’ve had a bunch of them recently as well.
Most scientists I know would be astonished that they are considered part of the amorphous, ill-defined and obviously malevolent global “elite”. Then “elite” is just one more proxy for “the other” something which it is not popular to be in various places in the world at present.
Or what passed for debate in these post-truth times.
Mr Gove studied English at Lady Margaret Hall, Oxford, where he was also President of the Oxford Union. Clearly Oxford produces less experts than it used to in previous eras.
One that is also probably wildly inaccurate and certainly incomplete.
So Newton’s celebrated theory of gravitation is “wrong” but actually works perfectly well in most circumstances. The the Rutherford–Bohr model, where atoms are little Solar Systems, with the nucleus circled by electrons much as the planets circle the Sun is “wrong”, but actually does serve to explain a number of things; if sadly not the orbital angular momentum of electrons.
Someone should really write a book about that – watch this space!
Not least in the aforementioned EU Referendum where it felt the need to follow the views of the vast majority of economists with those of the tiny minority, implying that the same weight be attached to both points of view. For example, 99.9999% of people believe the world to be round, but in the interests of balance my mate Jim reckons it is flat.
According to their web-site: “the world’s leading charity dedicated to beating cancer through research”.
As attested to personally by the only proper scientist in our family.
Unlike Oxford (according to Mr Gove anyway), Cambridge clearly still aspires to creating experts.
By this I mean proper science and not pseudo-science like management theory and the like.
In the original, non-J.K. Rowling sense of the phrase.
You must be logged in to post a comment.